Related references
Note: Only part of the references are listed.Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNF-α-dependent extrinsic apoptosis
Beata Pajak et al.
APOPTOSIS (2009)
Inhibition of NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel
Sun Mi Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts
Min Ji An et al.
CANCER LETTERS (2009)
Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells
Hideaki Karasawa et al.
CANCER SCIENCE (2009)
Expression of survivin and cortactin in colorectal adenocarcinoma: Association with clinicopathological parameters
Ying-Yu Lee et al.
DISEASE MARKERS (2009)
Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers
M. Wasif Saif et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs
Dan-Arin Silasi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
cIAP2 as a therapeutic target in colorectal cancer and other malignancies
Koh Miura et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer
Dermot T. McDowell et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer
Y. J. Fang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Design, Synthesis, and Evaluation of Potent, Nonpeptidic Mimetics of Second Mitochondria-Derived Activator of Caspases
Wei Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Expression of X-Linked Inhibitor of Apoptosis Protein in Human Colorectal Cancer and Its Correlation With Prognosis
Xiang Guoan et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines
Tsutomu Iwasa et al.
CLINICAL CANCER RESEARCH (2008)
Metachronous cancer development in patients with sporadic colorectal adenomas - multivariate risk model with independent and combined value of hTERT and survivin
Kjetil Soreide et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models
Franz Roedel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis
Mads Gyrd-Hansen et al.
NATURE CELL BIOLOGY (2008)
Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy
Cem Terzi et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy
Silke Lassmann et al.
GASTROENTEROLOGY (2007)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis
Massimo M. Santoro et al.
NATURE GENETICS (2007)
The inhibitor of apoptosis proteins as therapeutic targets in cancer
Domagoj Vucic et al.
CLINICAL CANCER RESEARCH (2007)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
The inhibitors of apoptosis (IAPs) as cancer targets
Allison M. Hunter et al.
APOPTOSIS (2007)
The alternative NF-κB pathway from biochemistry to biology:: Pitfalls and promises for future drug development
Emmanuel Dejardin
BIOCHEMICAL PHARMACOLOGY (2006)
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis
Eric C. LaCasse et al.
CLINICAL CANCER RESEARCH (2006)
Expression and localization of inhibitor of apoptosis proteins in normal human tissues
B Vischioni et al.
HUMAN PATHOLOGY (2006)
Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers
M Krajewska et al.
CLINICAL CANCER RESEARCH (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Drug therapy - Systemic therapy for colorectal cancer
JA Meyerhardt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death
L Li et al.
SCIENCE (2004)
Expression of IAP family proteins in colon cancers from patients with different age groups
T Endo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
The protein structures that shape caspase activity, specificity, activation and inhibition
P Fuentes-Prior et al.
BIOCHEMICAL JOURNAL (2004)
Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: Relationships with clinicopathological features and prognosis
T Ponnelle et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
The mitochondrial apoptosome: a killer unleashed by the cytochrome seas
C Adrain et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Structural basis of IAP recognition by Smac/DIABLO
G Wu et al.
NATURE (2000)
Proteases for cell suicide: Functions and regulation of caspases
HY Chang et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
CY Du et al.
CELL (2000)
Share Paper
